Preclinical Drug Development, Second Edition discusses the broad and complicated realm of preclinical drug development. Topics range from assessment of pharmacology and toxicology to industry trends and regulatory expectations to requirements that support clinical trials.
Highlights of the Second Edition include:
The book also includes case studies on preclinical pharmacokinetic-pharmacodynamic modeling and simulation in drug development, a review of ICH preclinical guidelines, and experimental methods used to study membrane drug transport and metabolism. This guide is a fundamental resource for medicinal chemists, biologists, and other specialists in the drug development sciences.
| ISBN: | 9781420084726 |
| Publication date: | 25th September 2009 |
| Author: | Mark C Rogge, David R Taft |
| Publisher: | CRC Press |
| Format: | Hardback |
| Pagination: | 359 pages |
| Series: | Drugs and the Pharmaceutical Sciences |
| Genres: |
Biology, life sciences Pharmaceutical chemistry and technology |
Preclinical Drug Development, Second Edition discusses the broad and complicated realm of preclinical drug development. Topics range from assessment of pharmacology and toxicology to industry trends and regulatory expectations to requirements that support clinical trials.
Preclinical Drug Development features in the following genres: Biology, life sciences, Pharmaceutical chemistry and technology
Hardback. £189.00, down from the £210.00 cover price. Not Available.
Preclinical Drug Development was written by Mark C Rogge, David R Taft and published by CRC Press
Preclinical Drug Development has 359 pages
Yes it is part of Drugs and the Pharmaceutical Sciences series
£189.00, reduced from £210.00. Not Available.